Ocean Power Technologies Issues Stockholder Vote and Meeting Reminder
MONROE TOWNSHIP, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), […]
JOYY Announces Leadership Transition
SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) — JOYY Inc. (Nasdaq: YY) (“JOYY” or the “Company”), a global technology company, today […]
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
Information regarding the total number of voting rights andtotal number of shares of the Company as of July 31, 2024 […]
Arhaus Unveils Studio in Peachtree City, Georgia
BOSTON HEIGHTS, Ohio, Aug. 02, 2024 (GLOBE NEWSWIRE) — Arhaus, a leader in artisan-crafted furniture and home décor, announces the […]
NexGold Mining Announces New OTCQX Ticker Symbol
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG) (OTCQX: NXGCF) (the “Company” or “NexGold“) is pleased […]
Management Update
MONTREAL, Aug. 02, 2024 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) announces that Mr. Vincent […]
FutureFuel Announces Director Resignation
CLAYTON, Mont., Aug. 02, 2024 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom […]
Cornerstone Funds Announce Continuing Monthly Distributions for 2024 and Distribution Percentage for 2025
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) — Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone […]
Greenridge Exploration Closes First Tranche of Flow Through Private Placement Financing
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British […]
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and […]
